1
|
Abstract
Barcoded bioassays are ready to promote bioanalysis and biomedicine toward the point of care.
Collapse
Affiliation(s)
- Mingzhu Yang
- Beijing Engineering Research Center for BioNanotechnology
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety
- CAS Center for Excellence in Nanoscience
- National Center for NanoScience and Technology
- Beijing
| | - Yong Liu
- Beijing Engineering Research Center for BioNanotechnology
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety
- CAS Center for Excellence in Nanoscience
- National Center for NanoScience and Technology
- Beijing
| | - Xingyu Jiang
- Beijing Engineering Research Center for BioNanotechnology
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety
- CAS Center for Excellence in Nanoscience
- National Center for NanoScience and Technology
- Beijing
| |
Collapse
|
2
|
Hernández-Neuta I, Neumann F, Brightmeyer J, Ba Tis T, Madaboosi N, Wei Q, Ozcan A, Nilsson M. Smartphone-based clinical diagnostics: towards democratization of evidence-based health care. J Intern Med 2019; 285:19-39. [PMID: 30079527 PMCID: PMC6334517 DOI: 10.1111/joim.12820] [Citation(s) in RCA: 95] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Recent advancements in bioanalytical techniques have led to the development of novel and robust diagnostic approaches that hold promise for providing optimal patient treatment, guiding prevention programs and widening the scope of personalized medicine. However, these advanced diagnostic techniques are still complex, expensive and limited to centralized healthcare facilities or research laboratories. This significantly hinders the use of evidence-based diagnostics for resource-limited settings and the primary care, thus creating a gap between healthcare providers and patients, leaving these populations without access to precision and quality medicine. Smartphone-based imaging and sensing platforms are emerging as promising alternatives for bridging this gap and decentralizing diagnostic tests offering practical features such as portability, cost-effectiveness and connectivity. Moreover, towards simplifying and automating bioanalytical techniques, biosensors and lab-on-a-chip technologies have become essential to interface and integrate these assays, bringing together the high precision and sensitivity of diagnostic techniques with the connectivity and computational power of smartphones. Here, we provide an overview of the emerging field of clinical smartphone diagnostics and its contributing technologies, as well as their wide range of areas of application, which span from haematology to digital pathology and rapid infectious disease diagnostics.
Collapse
Affiliation(s)
- I Hernández-Neuta
- Department of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Solna, SE, Sweden
| | - F Neumann
- Department of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Solna, SE, Sweden
| | - J Brightmeyer
- Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC, USA
| | - T Ba Tis
- Department of Materials Science and Engineering, North Carolina State University, Raleigh, NC, USA
| | - N Madaboosi
- Department of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Solna, SE, Sweden
| | - Q Wei
- Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC, USA
| | - A Ozcan
- Electrical and Computer Engineering Department, University of California Los Angeles, Los Angeles, CA, USA
| | - M Nilsson
- Department of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Solna, SE, Sweden
| |
Collapse
|
3
|
Zhuang B. Integrated Module for Automated DNA Extraction and Amplification. DEVELOPMENT OF A FULLY INTEGRATED “SAMPLE-IN-ANSWER-OUT” SYSTEM FOR AUTOMATIC GENETIC ANALYSIS 2018:63-87. [DOI: 10.1007/978-981-10-4753-4_3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/01/2023]
|
4
|
Yan D, Xiang G, Chai X, Qing J, Shang H, Zou B, Mittal R, Shen J, Smith RJH, Fan YS, Blanton SH, Tekin M, Morton C, Xing W, Cheng J, Liu XZ. Screening of deafness-causing DNA variants that are common in patients of European ancestry using a microarray-based approach. PLoS One 2017; 12:e0169219. [PMID: 28273078 PMCID: PMC5342170 DOI: 10.1371/journal.pone.0169219] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2016] [Accepted: 12/04/2016] [Indexed: 12/12/2022] Open
Abstract
The unparalleled heterogeneity in genetic causes of hearing loss along with remarkable differences in prevalence of causative variants among ethnic groups makes single gene tests technically inefficient. Although hundreds of genes have been reported to be associated with nonsyndromic hearing loss (NSHL), GJB2, GJB6, SLC26A4, and mitochondrial (mt) MT-RNR1 and MTTS are the major contributors. In order to provide a faster, more comprehensive and cost effective assay, we constructed a DNA fluidic array, CapitalBioMiamiOtoArray, for the detection of sequence variants in five genes that are common in most populations of European descent. They consist of c.35delG, p.W44C, p.L90P, c.167delT (GJB2); 309kb deletion (GJB6); p.L236P, p.T416P (SLC26A4); and m.1555A>G, m.7444G>A (mtDNA). We have validated our hearing loss array by analyzing a total of 160 DNAs samples. Our results show 100% concordance between the fluidic array biochip-based approach and the established Sanger sequencing method, thus proving its robustness and reliability at a relatively low cost.
Collapse
Affiliation(s)
- Denise Yan
- Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
| | - Guangxin Xiang
- National Engineering Research Center for Beijing Biochip Technology, Beijing, China
| | - Xingping Chai
- National Engineering Research Center for Beijing Biochip Technology, Beijing, China
- Tsinghua University School of Medicine, Beijing, China
| | - Jie Qing
- Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
| | - Haiqiong Shang
- Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
| | - Bing Zou
- Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
| | - Rahul Mittal
- Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
| | - Jun Shen
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
- Laboratory for Molecular Medicine, Partners Personalized Medicine, Cambridge, Massachusetts, United States of America
| | - Richard J. H. Smith
- Department of Otolaryngology - Head and Neck Surgery, Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States of America
| | - Yao-Shan Fan
- Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
- Dr. John T. Macdonald Department of Human Genetics and John P.Hussman Institute for Human Genetics, University of Miami Miller School of Medicine, Miami, Florida, United States of America
| | - Susan H. Blanton
- Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
- Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
| | - Mustafa Tekin
- Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
- Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
| | - Cynthia Morton
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
- Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
- Division of Evolution and Genomic Science, School of Biological Sciences, Manchester Academic Health Science Center, University of Manchester, United Kingdom
| | - Wanli Xing
- National Engineering Research Center for Beijing Biochip Technology, Beijing, China
- Tsinghua University School of Medicine, Beijing, China
| | - Jing Cheng
- National Engineering Research Center for Beijing Biochip Technology, Beijing, China
- Tsinghua University School of Medicine, Beijing, China
| | - Xue Zhong Liu
- Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
- Tsinghua University School of Medicine, Beijing, China
- Dr. John T. Macdonald Department of Human Genetics and John P.Hussman Institute for Human Genetics, University of Miami Miller School of Medicine, Miami, Florida, United States of America
| |
Collapse
|
5
|
Rapid identification of aminoglycoside-induced deafness gene mutations using multiplex real-time polymerase chain reaction. Int J Pediatr Otorhinolaryngol 2015; 79:1067-72. [PMID: 25959403 DOI: 10.1016/j.ijporl.2015.04.028] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/12/2015] [Revised: 04/16/2015] [Accepted: 04/17/2015] [Indexed: 10/23/2022]
Abstract
BACKGROUND Exposure to aminoglycoside antibiotics can induce ototoxicity in genetically susceptible individuals carrying certain mitochondrial DNA (mtDNA) mutations (C1494T and A1555G), resulting in hearing loss. So, a rapid diagnostic approach is needed to accurately identify subjects carrying such gene mutations. METHODS In the present study, we describe a rapid and reliable four-color, real-time quantitative polymerase chain reaction (qPCR) assay for simultaneously detecting two mtDNA 12S rRNA gene variants, A1555G and C1494T, which are prevalent in the Han Chinese population. This multiplex assay incorporates three allele-specific TaqMan probes labeled with different fluorophores in a single reaction, providing high genotyping accuracy for clinical blood samples. RESULTS Tests with C1494T, A1555G and wild-type DNA exhibited high sensitivity, specificity, reproducibility and accuracy of discriminating mutations from wild-type. CONCLUSIONS This study shows that this simple and inexpensive method can be used for routine molecular diagnostics and potentially for large-scale genetic screening.
Collapse
|
6
|
Wang S, Sun Y, Gan W, Liu Y, Xiang G, Wang D, Wang L, Cheng J, Liu P. An automated microfluidic system for single-stranded DNA preparation and magnetic bead-based microarray analysis. BIOMICROFLUIDICS 2015; 9:024102. [PMID: 25825617 PMCID: PMC4352165 DOI: 10.1063/1.4914024] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/05/2015] [Accepted: 02/18/2015] [Indexed: 05/25/2023]
Abstract
We present an integrated microfluidic device capable of performing single-stranded DNA (ssDNA) preparation and magnetic bead-based microarray analysis with a white-light detection for detecting mutations that account for hereditary hearing loss. The entire operation process, which includes loading of streptavidin-coated magnetic beads (MBs) and biotin-labeled polymerase chain reaction products, active dispersion of the MBs with DNA for binding, alkaline denaturation of DNA, dynamic hybridization of the bead-labeled ssDNA to a tag array, and white-light detection, can all be automatically accomplished in a single chamber of the microchip, which was operated on a self-contained instrument with all the necessary components for thermal control, fluidic control, and detection. Two novel mixing valves with embedded polydimethylsiloxane membranes, which can alternately generate a 3-μl pulse flow at a peak rate of around 160 mm/s, were integrated into the chip for thoroughly dispersing magnetic beads in 2 min. The binding efficiency of biotinylated oligonucleotides to beads was measured to be 80.6% of that obtained in a tube with the conventional method. To critically test the performance of this automated microsystem, we employed a commercial microarray-based detection kit for detecting nine mutation loci that account for hereditary hearing loss. The limit of detection of the microsystem was determined as 2.5 ng of input K562 standard genomic DNA using this kit. In addition, four blood samples obtained from persons with mutations were all correctly typed by our system in less than 45 min per run. The fully automated, "amplicon-in-answer-out" operation, together with the white-light detection, makes our system an excellent platform for low-cost, rapid genotyping in clinical diagnosis.
Collapse
|
7
|
Abstract
We describe here a compact smartphone-based fluorescence detector for mHealth. A key element to achieving high sensitivity using low sensitivity phone cameras is a capillary array, which increases sensitivity by 100×. The capillary array was combined with a white LED illumination system to enable wide spectra fluorescent excitation in the range of 450-740 nm. The detector utilizes an orthographic projection system to form parallel light projection images from the capillaries at a close distance via an object-space telecentric lens configuration that reduces the total lens-to-object distance while maintaining uniformity in measurement between capillaries. To further increase the limit of detection (LOD), a computational image processing approach was employed to decrease the level of noise. This enables an additional 5-10× decrease in LOD. This smartphone-based detector was used to measure serial dilutions of fluorescein with a LOD of 1 nM with image stacking and 10 nM without image stacking, similar to the LOD obtained with a commercial plate reader. Moreover, the capillary array required a sample volume of less than 10 μl, which is an order of magnitude less than the 100 μl required for the plate reader.As fluorescence detection is widely used in sensitive biomedical assays, the approach described here has the potential to increase mHealth clinical utility, especially for telemedicine and for resource-poor settings in global health applications.
Collapse
Affiliation(s)
- Joshua Balsam
- Division of Biology, Office of Science and Engineering, FDA, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA
| | | | | |
Collapse
|
8
|
Zhuang B, Gan W, Wang S, Han J, Xiang G, Li CX, Sun J, Liu P. Fully Automated Sample Preparation Microsystem for Genetic Testing of Hereditary Hearing Loss Using Two-Color Multiplex Allele-Specific PCR. Anal Chem 2014; 87:1202-9. [DOI: 10.1021/ac5039303] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- Bin Zhuang
- Department
of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, 100084, China
- Medical
Systems Biology Research Center, School of Medicine, Tsinghua University, Beijing, 100084, China
| | - Wupeng Gan
- Department
of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, 100084, China
- Medical
Systems Biology Research Center, School of Medicine, Tsinghua University, Beijing, 100084, China
- CapitalBio Corporation, Beijing, 102206, China
- National Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China
| | - Shuaiqin Wang
- Department
of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, 100084, China
- Medical
Systems Biology Research Center, School of Medicine, Tsinghua University, Beijing, 100084, China
| | - Junping Han
- Chinese Peoples Public Security University, Beijing, 100038, China
| | - Guangxin Xiang
- CapitalBio Corporation, Beijing, 102206, China
- National Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China
| | - Cai-Xia Li
- Institute
of Forensic Science, Key Laboratory of Forensic Genetics, Ministry of Public Security, Beijing, 100038, China
| | - Jing Sun
- Institute
of Forensic Science, Key Laboratory of Forensic Genetics, Ministry of Public Security, Beijing, 100038, China
| | - Peng Liu
- Department
of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, 100084, China
- Medical
Systems Biology Research Center, School of Medicine, Tsinghua University, Beijing, 100084, China
- Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, Zhejiang 310003, China
| |
Collapse
|
9
|
Balsam J, Rasooly R, Bruck HA, Rasooly A. Thousand-fold fluorescent signal amplification for mHealth diagnostics. Biosens Bioelectron 2014; 51:1-7. [PMID: 23928092 PMCID: PMC3795847 DOI: 10.1016/j.bios.2013.06.053] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2013] [Revised: 06/19/2013] [Accepted: 06/26/2013] [Indexed: 01/27/2023]
Abstract
The low sensitivity of Mobile Health (mHealth) optical detectors, such as those found on mobile phones, is a limiting factor for many mHealth clinical applications. To improve sensitivity, we have combined two approaches for optical signal amplification: (1) a computational approach based on an image stacking algorithm to decrease the image noise and enhance weak signals, and (2) an optical signal amplifier utilizing a capillary tube array. These approaches were used in a detection system which includes multi-wavelength LEDs capable of exciting many fluorophores in multiple wavelengths, a mobile phone or a webcam as a detector, and capillary tube array configured with 36 capillary tubes for signal enhancement. The capillary array enables a ~100× increase in signal sensitivity for fluorescein, reducing the limit of detection (LOD) for mobile phones and webcams from 1000 nM to 10nM. Computational image stacking enables another ~10× increase in signal sensitivity, further reducing the LOD for webcam from 10nM to 1 nM. To demonstrate the feasibility of the device for the detection of disease-related biomarkers, adenovirus DNA labeled with SYBR green or fluorescein was analyzed by both our capillary array and a commercial plate reader. The LOD for the capillary array was 5 ug/mL, and that of the plate reader was 1 ug/mL. Similar results were obtained using DNA stained with fluorescein. The combination of the two signal amplification approaches enables a ~1000× increase in LOD for the webcam platform. This brings it into the range of a conventional plate reader while using a smaller sample volume (10 ul) than the plate reader requires (100 ul). This suggests that such a device could be suitable for biosensing applications where up to 10 fold smaller sample sizes are needed. The simple optical configuration for mHealth described in this paper employing the combined capillary and image processing signal amplification is capable of measuring weak fluorescent signals without the need of dedicated laboratories. It has the potential to be used to increase sensitivity of other optically based mHealth technologies, and may increase mHealth's clinical utility, especially for telemedicine and for resource-poor settings and global health applications.
Collapse
Affiliation(s)
- Joshua Balsam
- Division of Biology, Office of Science and Engineering, FDA, Silver Spring, MD 20993, United States; University of Maryland, College Park, MD 20742, United States
| | | | | | | |
Collapse
|
10
|
Balsam J, Bruck HA, Rasooly A. Orthographic projection capillary array fluorescent sensor for mHealth. Methods 2013; 63:276-81. [PMID: 24018203 PMCID: PMC3902889 DOI: 10.1016/j.ymeth.2013.07.044] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2013] [Revised: 07/02/2013] [Accepted: 07/08/2013] [Indexed: 12/19/2022] Open
Abstract
To overcome the limited sensitivity of phone cameras for mobile health (mHealth) fluorescent detection, we have previously developed a capillary array which enables a ∼100 × increase in detection sensitivity. However, for an effective detection platform, the optical configuration must allow for uniform measurement sensitivity between channels when using such a capillary array sensor. This is a challenge due to the parallax inherent in imaging long parallel capillary tubes with typical lens configurations. To enable effective detection, we have developed an orthographic projection system in this work which forms parallel light projection images from the capillaries using an object-space telecentric lens configuration. This optical configuration results in a significantly higher degree of uniformity in measurement between channels, as well as a significantly reduced focal distance, which enables a more compact sensor. A plano-convex lens (f=150 mm) was shown to produce a uniform orthographic projection when properly combined with the phone camera's built in lens (f=4mm), enabling measurements of long capillaries (125 mm) to be made from a distance of 160 mm. The number of parallel measurements which can be made is determined by the size of the secondary lens. Based on these results, a more compact configuration with shorter 32 mm capillaries and a plano-convex lens with a shorter focal length (f=10mm) was constructed. This optical system was used to measure serial dilutions of fluorescein with a limit of detection (LOD) of 10nM, similar to the LOD of a commercial plate reader. However, many plate readers based on standard 96 well plate requires sample volumes of 100 μl for measurement, while the capillary array requires a sample volume of less than 10 μl. This optical configuration allows for a device to make use of the ∼100 × increase in fluorescent detection sensitivity produced by capillary amplification while maintaining a compact size and capability to analyze extremely small sample volumes. Such a device based on a phone or other optical mHealth technology will have the sensitivity of a conventional plate reader but have greater mHealth clinical utility, especially for telemedicine and for resource-poor settings and global health applications.
Collapse
Affiliation(s)
- Joshua Balsam
- Division of Biology, Office of Science and Engineering, FDA, Silver Spring, MD 20993, USA; University of Maryland, College Park, MD 20742, USA.
| | | | | |
Collapse
|
11
|
Balsam J, Bruck HA, Rasooly A. Capillary Array Waveguide Amplified Fluorescence Detector for mHealth. SENSORS AND ACTUATORS. B, CHEMICAL 2013; 186:711-717. [PMID: 24039345 PMCID: PMC3769705 DOI: 10.1016/j.snb.2013.06.030] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Mobile Health (mHealth) analytical technologies are potentially useful for carrying out modern medical diagnostics in resource-poor settings. Effective mHealth devices for underserved populations need to be simple, low cost, and portable. Although cell phone cameras have been used for biodetection, their sensitivity is a limiting factor because currently it is too low to be effective for many mHealth applications, which depend on detection of weak fluorescent signals. To improve the sensitivity of portable phones, a capillary tube array was developed to amplify fluorescence signals using their waveguide properties. An array configured with 36 capillary tubes was demonstrated to have a ~100X increase in sensitivity, lowering the limit of detection (LOD) of mobile phones from 1000 nM to 10 nM for fluorescein. To confirm that the amplification was due to waveguide behavior, we coated the external surfaces of the capillaries with silver. The silver coating interfered with the waveguide behavior and diminished the fluorescence signal, thereby proving that the waveguide behavior was the main mechanism for enhancing optical sensitivity. The optical configuration described here is novel in several ways. First, the use of capillaries waveguide properties to improve detection of weak florescence signal is new. Second we describe here a three dimensional illumination system, while conventional angular laser waveguide illumination is spot (or line), which is functionally one-dimensional illumination, can illuminate only a single capillary or a single column (when a line generator is used) of capillaries and thus inherently limits the multiplexing capability of detection. The planar illumination demonstrated in this work enables illumination of a two dimensional capillary array (e.g. x columns and y rows of capillaries). In addition, the waveguide light propagation via the capillary wall provides a third dimension for illumination along the axis of the capillaries. Such an array can potentially be used for sensitive analysis of multiple fluorescent detection assays simultaneously. The simple phone based capillary array approach presented in this paper is capable of amplifying weak fluorescent signals thereby improving the sensitivity of optical detectors based on mobile phones. This may allow sensitive biological assays to be measured with low sensitivity detectors and may make mHealth practical for many diagnostics applications, especially in resource-poor and global health settings.
Collapse
Affiliation(s)
- Joshua Balsam
- Division of Biology, Office of Science and Engineering, FDA, Silver Spring, MD 20993 ; University of Maryland, College Park, MD 20742
| | | | | |
Collapse
|
12
|
Zhu J, Song X, Xiang G, Feng Z, Guo H, Mei D, Zhang G, Wang D, Mitchelson K, Xing W, Cheng J. A rapid automatic processing platform for bead label-assisted microarray analysis: application for genetic hearing-loss mutation detection. ACTA ACUST UNITED AC 2013; 19:144-52. [PMID: 23975388 DOI: 10.1177/2211068213491096] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Molecular diagnostics using microarrays are increasingly being used in clinical diagnosis because of their high throughput, sensitivity, and accuracy. However, standard microarray processing takes several hours and involves manual steps during hybridization, slide clean up, and imaging. Here we describe the development of an integrated platform that automates these individual steps as well as significantly shortens the processing time and improves reproducibility. The platform integrates such key elements as a microfluidic chip, flow control system, temperature control system, imaging system, and automated analysis of clinical results. Bead labeling of microarray signals required a simple imaging system and allowed continuous monitoring of the microarray processing. To demonstrate utility, the automated platform was used to genotype hereditary hearing-loss gene mutations. Compared with conventional microarray processing procedures, the platform increases the efficiency and reproducibility of hybridization, speeding microarray processing through to result analysis. The platform also continuously monitors the microarray signals, which can be used to facilitate optimization of microarray processing conditions. In addition, the modular design of the platform lends itself to development of simultaneous processing of multiple microfluidic chips. We believe the novel features of the platform will benefit its use in clinical settings in which fast, low-complexity molecular genetic testing is required.
Collapse
Affiliation(s)
- Jiang Zhu
- 1CapitalBio Corporation, Beijing, P. R. China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|